The New Oncology Launch Environment

Posted by Sarah Hamilton on Apr 12, 2017 10:53:55 AM

Dave Cohen co-authored this blog post with Sarah Hamilton. 

With more than 650 new agents in development, oncology has been center stage for many pharmaceutical companies in recent years. Although unmet need remains high for many tumor types, this sizeable pipeline investment is expected to bring tremendous new promise to patients as drugs start hitting the market. Along with that promise, we suspect that it also will bring several commercial challenges for companies that are seeking to successfully launch an oncology asset into this new environment. 


>
Read More